January 31 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma's [BUL:SFA] standalone net profit dropped to 30.1 million levs ($16 million/15.4 million euro) in 2024 from some 47.6 million levs the prior year, the company said, citing preliminary data.